George H. Talbot
- Infectious Diseases top 0.2%
- Molecular Medicine top 0.05%
- Epidemiology top 0.5%
- Pharmacology top 0.2%
- Molecular Biology top 5%
- Co-authors
- John S. BradleyDavid N. GilbertHelen W. BoucherJohn E. EdwardsMichael ScheldBrad SpellbergLouis B. RiceJohn Bartlett
- Topics
- Antibiotics Pharmacokinetics and Efficacy (28 papers)Antimicrobial Resistance in Staphylococcus (27 papers)Bacterial Identification and Susceptibility Testing (24 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
George H. Talbot
115 papers receiving 9.6k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Infectious Diseases 3.7k
- Molecular Medicine 3.6k
- Epidemiology 2.5k
- Pharmacology 2.4k
- Molecular Biology 2.1k
Countries citing papers authored by George H. Talbot
This map shows the geographic impact of George H. Talbot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George H. Talbot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George H. Talbot more than expected).
Fields of papers citing papers by George H. Talbot
This network shows the impact of papers produced by George H. Talbot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George H. Talbot. The network helps show where George H. Talbot may publish in the future.
Co-authorship network of co-authors of George H. Talbot
This figure shows the co-authorship network connecting the top 25 collaborators of George H. Talbot. A scholar is included among the top collaborators of George H. Talbot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George H. Talbot. George H. Talbot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 47 | |
| 2 | 53 | |
| 3 | 5 | |
| 4 | Pulmonary Cavitation and Massive Hemoptysis in Invasive Pulmonary Aspergillosis | 2 |
| 5 | 1 | |
| 6 | 58 | |
| 7 | 27 | |
| 8 | 10 x '20 Progress--Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of Americabreakdown → | 555 |
| 9 | 195 | |
| 10 | 15 | |
| 11 | 43 | |
| 12 | Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of Americabreakdown → | 846 |
| 13 | 6 | |
| 14 | 6 | |
| 15 | 25 | |
| 16 | 30 | |
| 17 | 88 | |
| 18 | 12 | |
| 19 | 97 | |
| 20 | 1 |
About George H. Talbot
George H. Talbot is a scholar working on Clinical Biochemistry, Molecular Medicine and Applied Microbiology and Biotechnology, having authored 120 papers that have together received 10.1k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (28 papers), Antimicrobial Resistance in Staphylococcus (27 papers) and Bacterial Identification and Susceptibility Testing (24 papers). The work is most often cited by research in Molecular Medicine (3.6k citations), Applied Microbiology and Biotechnology (1.3k citations) and Clinical Biochemistry (1.6k citations). George H. Talbot has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include John S. Bradley, David N. Gilbert, Helen W. Boucher, John E. Edwards, Michael Scheld, Brad Spellberg, Louis B. Rice, John Bartlett, John G. Bartlett and Anita Das. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.